332. Thrombosis and Anticoagulation: Clinical and Epidemiological: Poster II

Utilization and outcomes of inferior vena cava IVC filters in patients with cancer associated acute venous thromboembolism hospitalizations Insights from the u S national inpatient sample 2018–2022

Title Role of primary VTE prophylaxis in pediatric leukemia lymphoma and solid tumors A systematic review and meta analysis

Incidence of arterial thromboembolism in patients with myeloproliferative neoplasms treated with anticoagulation for venous thromboembolism

Role in of primary VTE prophylaxis in pediatric patients in hospitalized and critically ill settings A systematic review and meta analysis

Risk factors and mortality associated with venous thromboembolism in elderly patients with non Hodgkin lymphoma

Antiplatelet therapy in anticoagulated cirrhotic patients with chronic portal vein thrombosis A retrospective multicenter study

Comparing the safety of direct oral anticoagulants vs low molecular weight heparin in patients with thrombocytopenia and venous thromboembolism

Plasma protein biomarkers associated with venous thromboembolism VTE and mortality in patients with cancer A substudy of the avert trial

Real world analysis of thromboprophylaxis use during autologous hematopoietic stem cell transplantation for lymphoma and multiple myeloma

Safety and effectiveness of standard versus extended duration of anticoagulation in children with acute lymphoblastic leukemia and venous thrombo embolism

Evaluating the effect of morbid obesity on DVT in patients already on doac therapy A retrospective analysis

Long term risk of thromboembolic events in patients with post acute sequelae of COVID 19 A retrospective propensity matched cohort study

Management and outcomes in patients with cryptogenic stroke and weakly positive antiphospholipid antibodies

Antithrombin deficiency venous thromboembolism risk and peripartum antithrombin supplementation A real world analysis of delivery encounters from 2015–2024

Analysis of no bolus versus bolus unfractionated heparin nomograms in the management of pulmonary embolism Insights from a real world cohort